บุคลากรสายวิชาการ

ผศ.ดร.ภญ. กันตรัตน์ อรุณรุ่งวิเชียร ผศ.ดร.ภญ. กันตรัตน์ อรุณรุ่งวิเชียร kuntarat.aru@mahidol.ac.th kuntarat.aru@mahidol.ac.th อาจารย์ประจำภาควิชาเภสัชเคมี

2021

1. Erianthridin suppresses non-small-cell lung cancer cell metastasis through inhibition of Akt/mTOR/p70(S6K) signaling pathway

   Pothongsrisit S, Arunrungvichian K, Hayakawa Y, Sritularak B, Mangmool S, Pongrakhananon V*. Scientific reports 2021; 11(1): 6618.
   
   

2020

1. α7-Nicotinic acetylcholine receptor antagonist QND7 suppresses non-small cell lung cancer cell proliferation and migration via inhibition of Akt/mTOR signaling.

   Witayateeraporn W, Arunrungvichian K, Pothongsrisit S, Doungchawee J, Vajragupta O, Pongrakhananon V*. Biochem biophys res commun 2020; 521(4): 977-983.
   
   

2. In silico finding of key interaction mediated α3β4 and α7 nicotinic acetylcholine receptor ligand selectivity of quinuclidine-triazole chemotype

   Arunrungvichian K, Chongruchiroj S, Sarasamkan J, Schüürmann G, Brust P, Vajragupta O*. International journal of molecular sciences 2020; 21(17): 6189: 1-18.
   
   

3. Relationships between amyloid levels, glucose metabolism, morphologic changes in the brain and clinical status of patients with Alzheimer’s disease

   Thientunyakit T*, Sethanandha C, Muangpaisan W, Chawalparit O, Arunrungvichian K, Siriprapa T, Vichianin Y, Kamal S, Suppasilp C, Thongpraparn T, Chanachai R. Annals of nuclear medicine 2020; 34(5): 337-348.
   
   

2019

1. A Novel Multi-Modali Molecular Imaging Index of yloid, Glucose Metabolism, and Morphologic Changes in the Brain for Evaluation of Patients th Dementia:A Thailand Perspective.

   Thientunyakit T, Sethanandha C, Muangpaisan W, Chawalparit O, Arunrungvichian K*, Siriprapa T, Kamal S, Thongpraparn T, Vichianin Y, Chanachai R, Gelovani J. Journal of Nuclear Medicine 2019; 60(1).
   
   

2. Preliminary in vitro permeability, cytotoxicity and cardiotoxicity evaluation of triazole-quinuclidine T6

   Arunrungvichian K*, Khongkaew P, Panyasang S, Sarasamkan J. Pharmaceutical Sciences Asia 2019; 43(3); 156-162.
   
   

2018

1. Implementation of [ 18 F]-labeled amyloid brain PET imaging biomarker in the diagnosis of alzheimer’s disease: first-hand experience in Thailand

   Thientunyakit T*, Sethanandha C, Muangpaisan W, Chawalparit O, Arunrungvichian K, Siriprapa T, Thongpraparn T, Chanachai R, Gelovani J. Nuclear Medicine Communications 2018; 39(2): 186-192
   
   

2017

1. Radiosynthesis of (S)-[18F]T1: The first PET radioligand for molecular imaging of α3β4 nicotinic acetylcholine receptors

   Sarasamkan J, Fischer S, Deuther-Conrad W, Ludwig F-A, Scheunemann M, Arunrungvichian K, Vajragupta O, Brust P*. Applied Radiation and Isotopes 2017; 124: 106-113.
   
   

2016

1. Design and Synthesis of Nicotinic Acetylcholine Receptor Antagonists and their Effect on Cognitive Impairment

   Jaikhan P, Boonyarat C, Arunrungvichian K, Taylor P, Vajragupta O*. Chemical Biology & Drug Design 2016; 87(1): 39-56.
   
   

2. Varying Chirality Across Nicotinic Acetylcholine Receptor Subtypes: Selective Binding of Quinuclidine Triazole Compounds.

   Sarasamkan J, Scheunemann M, Apaijai N, Palee S, Parichatikanond W, Arunrungvichian K, Fischer S, Chattipakorn S, Deuther-Conrad W, Schüürmann G, Brust P, Vajragupta O. ACS Medicinal Chemistry Letters 2016; 7(10): 890-895.
   
   

2015

1. Cognitive improvement in a mouse model with substituted 1,2,3-triazole agonists for nicotinic acetylcholine receptors.

   Arunrungvichian K, Boonyarat C, Fokin VV, Taylor P, Vajragupta O*. ACS Chemical Neuroscience 2015, 6(8):1331-40.
   
   

2. Selectivity Optimization of Substituted 1,2,3-Triazoles as α7 Nicotinic Acetylcholine Receptor Agonists

   Arunrungvichian K, Fokin VV, Vajragupta O*, Taylor P. ACS Chemical Neuroscience 2015; 6(8): 1317-1330
   
   

---

หมายเหตุ: ชื่อที่ใช้ในการทำวิจัยของ ผศ.ดร.ภญ. กันตรัตน์ อรุณรุ่งวิเชียร ได้แก่ Arunrungvichian K ;